Retatrutide is in Phase III development (not yet approved). In a Phase II trial (338 patients, 48 weeks), the highest dose achieved 24.2% body weight loss compared to 2.1% with placebo, with 100% o...
View full compound profile →Vendors stocking
21
across 6 countries
Total listings
35
34 in stock
Price range
€54.95–€399.95
Median price per mg
€10.00
Most common size
10mg
9 listings
Forms available
pen, lyophilised, Lyophilized Powder, injectiepen
Stock health
97%
20 vendors · 34 listings
8 vendors · 10 listings
£59.99–£169.99
Avg £10.18/mg
5 vendors · 13 listings
€54.95–€399.95
Avg €10.39/mg
5 vendors · 5 listings
CA$89.99–CA$180.00
Avg CA$12.12/mg
1 vendor · 1 listing
1 vendor · 1 listing
€129.00
1 vendor · 5 listings
$64.00–$390.00
Avg $10.65/mg
5mg
2 listings
Avg price: €87.00
Avg per mg: €17.40
10mg
9 listings
Avg price: €104.44
Avg per mg: €10.44
15mg
3 listings
Avg price: €154.97
Avg per mg: €10.33
20mg
5 listings
Avg price: €172.38
Avg per mg: €8.62
30mg
3 listings
Avg price: €338.30
Avg per mg: €11.28
40mg
2 listings
Avg price: €387.45
Avg per mg: €9.69
This compound is currently in clinical trials and is not yet approved for commercial sale. Information is for research reference only.
Prices last updated: 15 May 2026
Data sourced from 21 vendor websites across 6 countries
